Precision Medicine in Phaeochromocytoma and Paraganglioma.
Challis, Benjamin G
Casey, Ruth T
J Pers Med
MetadataShow full item record
Winzeler, B., Challis, B. G., & Casey, R. T. (2021). Precision Medicine in Phaeochromocytoma and Paraganglioma.. J Pers Med, 11 (11) https://doi.org/10.3390/jpm11111239
Precision medicine is a term used to describe medical care, which is specifically tailored to an individual patient or disease with the aim of ensuring the best clinical outcome whilst reducing the risk of adverse effects. Phaeochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumours with uncertain malignant potential. Over recent years, the molecular profiling of PPGLs has increased our understanding of the mechanisms that drive tumorigenesis. A high proportion of PPGLs are hereditary, with non-hereditary tumours commonly harbouring somatic mutations in known susceptibility genes. Through detailed interrogation of genotype-phenotype, correlations PPGLs can be classified into three different subgroups or clusters. Thus, PPGLs serve as an ideal paradigm for developing, testing and implementing precision medicine concepts in the clinic. In this review, we provide an overview of PPGLs and highlight how detailed molecular characterisation of these tumours provides current and future opportunities for precision oncology.
personalized medicine, neuroendocrine tumours, phaeochromocytoma, paraganglioma, molecular clusters
GIST SUPPORT UK (n/a)
External DOI: https://doi.org/10.3390/jpm11111239
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331049
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: email@example.com